Rifat Sarker Aoyon¹, Ismail Hossain², M. Abdullah-Al-Wadud³, Jia Uddin^4,*

CMES-Computer Modeling in Engineering & Sciences, Vol.142, No.3, pp. 2617-2640, 2025, DOI:10.32604/cmes.2025.060917 - 03 March 2025

Abstract This research introduces a unique approach to segmenting breast cancer images using a U-Net-based architecture. However, the computational demand for image processing is very high. Therefore, we have conducted this research to build a system that enables image segmentation training with low-power machines. To accomplish this, all data are divided into several segments, each being trained separately. In the case of prediction, the initial output is predicted from each trained model for an input, where the ultimate output is selected based on the pixel-wise majority voting of the expected outputs, which also ensures data privacy.… More >

Lingling Zhang^1,2, Hualing Wang³, Yawen Liu², Ling Li^2,*, Jianping Xiong^1,4,*

BIOCELL, Vol.49, No.2, pp. 253-267, 2025, DOI:10.32604/biocell.2025.061585 - 28 February 2025

Abstract Objective: Anillin (ANLN) is considered an oncogene in various cancers, but its effect on cervical cancer remains poorly understood. Hence, this study aimed to describe the action of ANLN on cervical cancer development and investigate the potential mechanism. Methods: Analysis of ANLN expression and its association with survival in carcinoma and endocervical adenocarcinoma (CESC) patients based on GEO and UALCAN databases. The tumor and adjacent normal tissues of 100 cervical cancer cases were harvested to detect the ANLN expression and explore its relationship with patient survival. Cell proliferation, apoptosis, migration, and invasion were measured by… More >

Chang-Eui Hong¹, Su-Yun Lyu^2,*

BIOCELL, Vol.49, No.2, pp. 289-314, 2025, DOI:10.32604/biocell.2025.061334 - 28 February 2025

Abstract Objectives: Among cutaneous malignancies, melanoma stands out for its particularly aggressive nature, with therapeutic interventions becoming notably limited once the disease progresses. In this research, we investigate the tumor-suppressing capabilities of water-extracted Korean mistletoe (Viscum album var. coloratum) and its purified lectin component (V. album var. coloratum agglutinin, VCA) using two distinct mouse melanoma models: B16BL6 and B16F10 cell lines. Methods: The impact of water extract and VCA treatments on melanoma cells was assessed through multiple experimental approaches, examining cellular survival rates, programmed cell death pathways, multicaspase activity, and cell cycle distribution patterns. To elucidate the interconnections among… More >

Qian Yang, Alina Leonie Ruff, Lydia Meder^*

BIOCELL, Vol.49, No.2, pp. 161-165, 2025, DOI:10.32604/biocell.2025.060227 - 28 February 2025

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.33, No.3, pp. 739-739, 2025, DOI:10.32604/or.2024.056911 - 28 February 2025

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.33, No.3, pp. 737-737, 2025, DOI:10.32604/or.2024.056910 - 28 February 2025

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.33, No.3, pp. 735-735, 2025, DOI:10.32604/or.2024.056907 - 28 February 2025

Abstract This article has no abstract. More >

Oncology Research Editorial Office

Oncology Research, Vol.33, No.3, pp. 733-733, 2025, DOI:10.32604/or.2024.056906 - 28 February 2025

Abstract This article has no abstract. More >

BELARDINILLI FRANCESCA^1,#, MICHELA DE MEO^1,#, FRANCESCO DEL GIUDICE², CARLO MARIA SCORNAJENGHI², PAOLA GAZZANIGA¹, ETTORE DE BERARDINIS², LUCA MARINO³, FABIO MASSIMO MAGLIOCCA⁴, BENJAMIN INBEH CHUNG⁵, JAN ŁASZKIEWICZ⁶, VALENTINA MAGRI⁴, GIUSEPPE GIANNINI^1,7, CHIARA NICOLAZZO^1,*

Oncology Research, Vol.33, No.3, pp. 723-731, 2025, DOI:10.32604/or.2024.056282 - 28 February 2025

Abstract Objectives: Intravesical Bacillus Calmette-Guérin (BCG) therapy is a gold standard for patients with high-risk non-muscle invasive bladder cancer (NMIBC). Although a long-lasting therapeutic response is observed in most patients, BCG failure occurs in 30%–50% of patients and a progression to muscle-invasive disease is found in 10%–15%. Therefore, predicting high-risk patients who might not benefit from BCG treatment is critical. The purpose of this study was to identify, whether the presence of specific oncogenic mutations might be indicative of BCG treatment response. Methods: Nineteen high-grade NMIBC patients who received intravesical BCG were retrospectively enrolled and divided… More > Graphic Abstract

IOANA MARIA MIHAI¹, GANG WANG^1,2,*

Oncology Research, Vol.33, No.3, pp. 533-547, 2025, DOI:10.32604/or.2024.055155 - 28 February 2025

Abstract The advent of precision medicine has underscored the importance of biomarkers in predicting therapy response for bladder cancer, a malignancy marked by considerable heterogeneity. This review critically examines the current landscape of biomarkers to forecast treatment outcomes in bladder cancer patients. We explore a range of biomarkers, including genetic, epigenetic, proteomic, and transcriptomic indicators, from multiple sample sources, including urine, tumor tissue and blood, assessing their efficacy in predicting responses to chemotherapy, immunotherapy, and targeted therapies. Despite promising developments, the translation of these biomarkers into clinical practice faces significant challenges, such as variability in biomarker More >